Marathi | HIndi

Epaper
Follow us:
Home > National > Serum Institute of India: Hotspots in Mumbai & Pune areas to help test COVID-19 vaccine effectiveness
Serum Institute of India: Hotspots in Mumbai & Pune areas to help test COVID-19 vaccine effectiveness English.Lokmat.com

Serum Institute of India: Hotspots in Mumbai & Pune areas to help test COVID-19 vaccine effectiveness

The increasing number of COVID-19 cases in Mumbai and Pune will contribute in testing the effectiveness of the vaccine ...
Serum Institute of India: Hotspots in Mumbai & Pune areas to help test COVID-19 vaccine effectiveness

The increasing number of COVID-19 cases in Mumbai and Pune will contribute in testing the effectiveness of the vaccine made by Oxford University and AstraZeneca, said its local manufacture Serum Institute of India.

SII said that by the end of August around 4,000 to 5,000 people in both Mumbai and Pune will be tested with the vaccine as part of trials that will continue for two months.

The vaccine candidate developed by Oxford University and AstraZeneca has shown satisfactory progress from the vaccines test results and is furter conducting larger field tests in the United Kingdom.

In India, it has chosen SII as manufacturing partner, which has to conduct field trials before getting the final nod to ensure they are safe and effective for Indians.

The company's chief executive Adar Poonawalla said, as Mumbai & Pune have maximum cases, we have shortlisted many hotspots that will help us understand the effectiveness of the vaccine.  

SII plans to start the phase-3 trials of the vaccine named 'Covishield' in India by August after getting a nod from the Drug Controller General of India.

"The Indian regulatory authorities have aided us in fast-tracking approvals keeping in mind the requisite guidelines of safety and efficacy, Poonawalla said. We do not want to rush and would focus only on delivering a viable and effective product for the masses, he said.

"Our facility is well-equipped with state-of-the-art technology to manufacture the COVID-19 vaccine. We plan to start production post regulatory approvals, Poonawala said.
 

Serum Institute of India: Hotspots in Mumbai & Pune areas to help test COVID-19 vaccine effectiveness
122 NDRF teams deployed in 20 states
603 out of 818 universities have conducted exams or are planning to conduct them: UGC
J-K: One killed, four missing after car plunges into Kagote Nulla in Udhampur
Residents of Piduguralla in Andhra oppose COVID Care hospital in residential area
Corona
Patients2088611
Died42518
Corona
Patients19,784,534
Died728,541
Corona
Coronavirus Live updates! Around the world